Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. charges former Outcome Health executives over alleged fraud

Published 11/25/2019, 01:51 PM
Updated 11/25/2019, 01:55 PM
U.S. charges former Outcome Health executives over alleged fraud

By Jonathan Stempel

(Reuters) - U.S. prosecutors announced criminal charges accusing the founders of Outcome Health of overseeing a fraudulent scheme to overbill clients and raise $487.5 million in financing from major investors.

Former Chief Executive Rishi Shah, former President Shradha Agarwal and two other former executives of the pharmaceutical advertising company were charged in a 26-count indictment in Chicago made public on Monday.

The charges were announced by the U.S. Department of Justice four weeks after Outcome agreed to pay $70 million to end its related criminal probe.

Outcome Health streams pharmaceutical ads on televisions and computer tablets it installs in doctors' offices.

Prosecutors said the defendants maintained a facade of "extraordinary revenue growth" through a scheme from 2011 to 2017 in which Outcome overstated its industry connections, billed clients for ads that never ran and inflated revenue.

They said this enabled the Chicago-based company to attract investors, such as affiliates of Goldman Sachs Group Inc (NYSE:GS), Google parent Alphabet (NASDAQ:GOOGL) Inc and Pritzker Group, and obtain a $5 billion valuation by 2017. Forbes magazine in 2017 estimated Shah's net worth at $3.6 billion.

Former Outcome Chief Financial Officer Brad Purdy and former Executive Vice President Ashik Desai were also charged in the indictment. Each count names one to three defendants, and Desai was named on one count.

The U.S. Securities and Exchange Commission filed related civil charges against the defendants.

William Burck, a lawyer for Shah, said in a statement that his client was being "scapegoated" for the wrongdoing of others who cut deals with prosecutors. "Mr. Shah will plead not guilty to these charges because he is, in fact, not guilty," Burck said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Christina Egan, a lawyer for Agarwal, said in response to the SEC lawsuit that her client denied the agency's allegations and would defend herself in court. "Shradha never committed fraud and never participated in any conspiracy," Egan said.

Purdy's lawyer had no immediate comment. A lawyer for Desai did not immediate respond to requests for comment.

Shah and Agarwal co-founded Outcome at 2006 while attending Northwestern University. Prosecutors said Shah owned an 80% stake, while Agarwal owned 20%.

Outcome's $70 million settlement, most of which has been paid, included a three-year non-prosecution agreement.

The company said in May it sold a majority stake to private equity firm Littlejohn & Co as part of a recapitalization.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.